6% Of New TB Infections In West Africa Resistant To Drugs, New Research Shows

The Guardian: Multidrug-resistant TB rates soaring in West Africa, WHO warns
“…Until now, the World Health Organization has had to rely on estimates for MDR-TB in West Africa because the data has not been collected or reliable. But a new surveillance network across eight countries in the region has found that drug resistance is a much greater threat than had been assumed. The WHO had estimated that up to two percent of new TB infections in West Africa were resistant to drugs, but the researchers found the true rate was six percent…” (Boseley, 11/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.